Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on metal free. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a cost-effective, metal-free synthesis method for 3,4,5-trisubstituted 1,2,4-triazoles. Eliminate anhydrous conditions and heavy metal catalysts to reduce production costs and supply chain risks.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Discover a cost-effective, palladium-free synthesis of Vismodegib with 99% purity. Eliminate anhydrous/oxygen-free requirements and reduce supply chain risks for your oncology projects.
Solve high-cost, low-yield issues in tegrazan intermediate production. New route achieves ≥99% purity with simplified steps and 100kgs+ scale capability.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.
Discover how metal-free, photo-catalyzed synthesis of perfluoroalkyl benzimidazoloisoquinolinones reduces costs and supply chain risks for pharmaceutical intermediates. Contact us for custom synthesis.
Discover how iodine-catalyzed metal-free synthesis of 3-arylthioimidazo[1,5-a]N-heterocycles solves transition metal contamination risks and improves yield for pharmaceutical intermediates.
Discover a cost-efficient, scalable synthesis method for furo[3,2-b]pyridine derivatives, eliminating precious metal use and reducing production costs for JAK1 inhibitor development.
Discover a green, high-yield route for S,S-2,8-diazabicyclononane that eliminates expensive reagents and reduces waste, ensuring supply chain stability for moxifloxacin manufacturing.
Discover a novel tadalafil synthesis method with 91.5% yield, eliminating hazardous piperonal and reducing equipment costs. Ideal for pharma R&D and procurement teams seeking scalable, eco-friendly production.
Discover how copper-catalyzed trifluoromethylation enables efficient quinazolinone synthesis for AChE/BuChE inhibition. Reduce production costs and scale complex molecules with CDMO expertise.
Solve NMR imaging agent supply chain risks with this patent-validated synthesis. 92-96% yields, no toxic reagents, and 75%+ step recovery. Scale to 100MT/yr.
Solve chiral ligand supply chain risks with this metal-free synthesis. 86% yield, no resolution needed. Contact for custom production.
Solve acetamiprid production challenges: 98% purity, 93% yield, 10x water reuse, and 90% less wastewater. Reduce costs and environmental impact.
Discover how visible light catalysis enables 90% yield 3-alkylquinoxaline-2(1H)-ketone synthesis at room temperature, reducing production costs and safety risks for pharmaceutical intermediates.
Discover how electrochemical catalysis eliminates metal catalysts and harsh conditions in benzyl alcohol production, reducing costs and supply chain risks for pharmaceutical intermediates. Contact us for scalable solutions.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for pharma R&D and production.
Discover a one-pot, metal-free synthesis for spiro-oxindole oxirane derivatives with 87-99% yield. Eliminate expensive equipment and accelerate drug discovery.
Solve transition metal catalyst costs and oxidation risks in sulfoxide synthesis. Our CDMO expertise delivers 82% yield o-amino aryl sulfoxides for drug development with 99% purity.
Discover a metal-free, water-based synthesis for 3-hydroxyisoindol-1-one with 88% yield. Eliminate organic solvents, reduce costs, and ensure high purity for pharmaceutical production.